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Abstract
Among livestock, domestic pig (Sus scrofa) is a species, in which iron metabolism has
been most intensively examined during last decade. The obvious reason for studying the
regulation of iron homeostasis especially in young pigs is neonatal iron deficiency anemia
commonly occurring in these animals. Moreover, supplementation of essentially all com-
mercially reared piglets with iron entails a need for monitoring the efficacy of this routine
practice followed in the swine industry for several decades. Since the discovery of hepcidin
many studies confirmed its role as key regulator of iron metabolism and pointed out the
assessment of its concentrations in biological fluids as diagnostic tool for iron-related disor-
der. Here we demonstrate that urine hepcidin-25 levels measured by a combination of weak
cation exchange chromatography and time-of-flight mass spectrometry (WCX-TOF MS) are
highly correlated with mRNA hepcidin expression in the liver and plasma hepcidin-25 con-
centrations in anemic and iron-supplemented 28-day old piglets. We also found a high cor-
relation between urine hepcidin level and hepatic non-heme iron content. Our results show
that similarly to previously described transgenic mouse models of iron disorders, young
pigs constitute a convenient animal model to explore accuracy and relationship between
indicators for assessing systemic iron status.
Introduction
Hepcidin is a 25-amino acid peptide hormone that regulates iron balance. It is synthesized
mainly by hepatocytes, released into the circulation, and excreted in urine by the kidneys [1].
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Increased levels of iron in the plasma and in iron storage sites stimulate the production of hep-
cidin [2], whereas iron deficiency down-regulates its synthesis [3]. Other studies have revealed
that hepcidin inhibits cellular efflux of iron by binding to ferroportin, the sole cellular iron
exporter, which is present on the surface of macrophages of the reticuloendothelial system,
duodenal enterocytes and hepatocytes. The binding precedes subsequent internalization and
degradation of ferroportin in lysosomes [1]. The above-described feedback regulation between
iron and hepcidin controls the appropriate physiological concentration of iron in the plasma
and its bioavailability for many vital processes including erythropoiesis. Accordingly, as previ-
ously shown, hepcidin deficiency leads to iron overload [4] and the overexpression of hepcidin
causes severe iron deficiency in transgenic mice [5]. After being identified as a key iron regula-
tory peptide, hepcidin has been put forward as a potentially valuable diagnostic marker for
iron-related disorders [6]. In this regard, a number of analytical methods have been developed
in order to assess hepcidin concentration in serum and in urine [7], [8].
Iron deficiency anemia (IDA) is a worldwide human pathology occurring also, to a greater
or lesser extent, in newborn pigs of all breeds [9], [10]. Considering that the red blood cell pool
is the largest functional iron compartment in the body, it is comprehensible that insufficient
iron stores and inadequate dietary intake observed in piglets, result for those animals in dis-
turbed iron balance and reduced, iron supply for their erythropoiesis. Therefore, to counteract
the development of anemia in young pigs, an exogenous iron source must be administered rou-
tinely, with the most common method being an intramuscular injection of a large amount of
iron dextran (150 mg Fe/kg piglet) [11]. This treatment dramatically shifts iron status of piglets
from severe iron depletion to iron repletion, or even a slight iron overload [12], [13], [14], [15].
Therefore, anemic and iron-supplemented piglets are considered to be a suitable animal mod-
els of the opposite profiles of iron metabolism and can be successfully employed to explore the
usefulness and accuracy of various indicators (such as hepcidin level in urine or in plasma, bio-
chemical iron parameters in plasma and RBC indices) in the estimation of systemic iron status.
In this study, we validated for the first time the usefulness of a combination of weak cation
exchange chromatography and the time-of-flight mass spectrometry (WCX-TOFMS) methods
for a reliable quantification pig hepcidin-25 in urine by measuring this parameter in 28-day old
piglets. The animals were divided and appropriately supplemented (or not) to have two groups
of animals with an opposite iron status: iron-deficient (anemic) and iron-overloaded (iron-
supplemented) piglets. In both groups of animals we demonstrate that urine hepcidin-25 con-
centrations strongly correlate with hepatic hepcidin mRNA abundance, plasma hepcidin-25
levels, iron transferrin saturation and non-heme liver iron levels. Our study shows how com-
prehensive evaluation of hepcidin expression may help in the diagnosis of iron deficiency and
its treatment in piglets.
Materials and Methods
Ethics Statement
Use of animals in the experiment and all procedures were approved by the Third Local Ethical
Committee on Animal Testing at the Warsaw University of Life Sciences—SGGW inWarsaw
(permission no. 55/2012).
Animals, experimental design, and samples collection
Experiments were conducted at the pig farm Brzezie belonging to the National Research
Institute of Animal Production (Balice, Poland). A total of 14 Polish Landrace x Polish Large
White piglets housed in standard conditions (approx. 70% humidity and a temperature of
22°C in standard cages with straw bedding) were used in the experiments. During the 28-day
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experiment sows were allowed to nurse their piglets. The feed (Prestarter, was manufactured at
the feed mill of the Experimental Station of the National Research Institute of Animal Produc-
tion in Brzezie; iron content 0.75 mg Fe/kg feed mixture) was offered to piglets from day 3 to
day 28. Piglets were taken from 3 litters delivered by 3 multipara sows. They were allotted to
two experimental groups (7 piglets per group) on the basis of balanced body weight (b.w.) at
birth: A) control piglets with no iron supplementation B) piglets routinely supplemented by
intramuscular injection with 150 and 40 mg Fe/kg b.w. on days 3 and 21 postpartum, respec-
tively. Iron was administered to piglets by intramuscular injection in the neck in the form of
iron dextran (FeDex), a complex of ferric ions with low molecular weight dextran (Ferran 100,
Vet-Agro, Lublin, Poland). Blood and urine as well as liver samples were taken for analyses
from all piglets on day 28 of life. Blood was drawn by venipuncture of the jugular vein (Vena
jugularis externa) into tubes coated with heparin as an anticoagulant. Blood was immediately
spun down (4°C, 2000 rpm, 10 min) to collect plasma. Piglets were euthanized by the intracar-
diac injection of Morbital (Biowet, Puławy, Poland). Urine was collected post mortem by uri-
nary bladder puncture. Plasma and urine samples were immediately aliquoted and stored at
-80°C. Liver samples were frozen in liquid nitrogen and kept at -80°C until they were analyzed
for hepcidin mRNA expression and non-heme iron content.
Real-time quantitative reverse transcription-polymerase chain reaction
analysis of hepatic hepcidin mRNA abundance
Total cellular RNA was extracted from liver samples (20 mg) using Trizol reagent (Invitrogen)
according to the manufacturer’s protocol. Two micrograms of total DNAse-treated RNA were
used for reverse transcription using a Transcriptor First Strand cDNA Synthesis Kit (ROCHE,
Switzerland). Real-time quantitative RNA analysis was performed in a Light Cycler U96
(Roche Diagnostics, Mannheim, Germany) using the respective pairs of oligonucleotide prim-
ers: hepc F: 3’ aagacagctcacagacctcc 5’; hepcR: 5’ ctacgtcttgcagcacatcc 3’, and s18F: 5’ aggaaagca
gacatcgacct 3’, s18R: 5’ acctggctgtacttcccatc 3’. Amplified products were detected using SYBR
Green I (Roche Diagnostics) as described previously [16]. To confirm amplification specificity,
the PCR product was subjected to melting curve analysis and agarose gel electrophoresis. Light
Cycler U96 Software was used for data analysis. Expression was normalized relative to that of
control transcript encoding 18S rRNA selected among other reference genes using NormFinder
software (http://www.mdl.dk/publicationsnormfinder.htm).
Hemoglobin level and quantitative hepatic non-hem iron measurement
Hemoglobin level (HGB), was determined using an automated ADVIA 2010 analyzer (Sie-
mens, Germany). The non-heme iron content of liver fragments (100 mg) was determined by
acid digestion of the samples at 100°C for 10 h, followed by colorimetric measurement of the
absorbance of the iron-ferrozine complex at 560 nm as described previously (Torrance and
Bothwell, 1980).
Hepatic iron staining
Non-heme iron deposits were analysed using Accustain Iron Deposition Kit (Sigma Aldrich).
Briefly, liver samples were excised immediately after sacrifice and fixed in Bouin’s solution for
24h, then stored in 70% ethanol. After embedding in paraffin, the samples were cut into 7-μm
sections with a microtome (Reichert-Jung, Germany). The sections were placed on a slide,
deparaffinised and hydrated tissues were incubated with working solution containing Perls’
Prussian Blue for 30 min. Slide were counterstained with pararoseaniline solution for 2 min
and analysed under standard light microscopy (Olympus, type CH2).
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Plasma iron concentration and transferrin saturation
Plasma iron concentration and total iron binding capacity (TIBC) were determined by colori-
metric measurement of the absorbance of the iron-chromazurol complex at 630 nm according
to manufacturer protocol (Alpha Diagnostic, Poland). Percent of transferrin saturation
(TSAT) was then calculated according to the following formula: TSAT = (plasma iron/TIBC) ×
100.
Plasma hepcidin-25 quantification
Piglet plasma hepcidin-25 measurements were performed by a combination of weak cation
exchange chromatography and time-of-flight mass spectrometry (WCX-TOFMS), as
described previously for human and porcine plasma samples [17], [7], [15]. In short, acetonitril
and a synthetic human hepcidin-25 standard (Peptide International Inc.) were added to the
samples. The resulting solution was mixed and centrifuged at 27500 x g for 5 min., after which
the supernatant was collected. Weak cationic exchange beads (Macro-Prep Support Beads;
Bio-Rad Laboratories) and binding buffer were added to the supernatant, which was mixed
thoroughly. The solution was incubated for 15 min. on the rollerbank at RT to allow hepcidin
to bind to the beads. Next, the beads were washed three times and the bound hepcidin was
eluted from the beads using elution buffer consisting of acetonitril and trifluoroacetic acid. The
eluted fraction was spotted onto a MSP 96 polished steel target plate (Bruker Daltonics) fol-
lowed by an energy-absorbing matrix (5 mg/mL α-cyano-4-hydroxy cinnamic acid (Bruker
Daltonics). Peptide spectra were generated on a Microflex LT matrix-enhanced laser desorp-
tion/ionisation TOFMS platform (Bruker Daltonics). The concentration of pig hepcidin-25
was calculated by comparing its mass peak height with that of the internal standard. Piglet
plasma hepcidin-25 concentrations were expressed as nmol/L (nM). The lower limit of detec-
tion of this method was 1 nM.
Urine Hepcidin-25 Quantification
For the first time piglet urine hepcidin-25 measurements were performed by a combination of
weak cation exchange chromatography and time-of-flight mass spectrometry (WCX-TOF
MS), as described previously for pig plasma [15].
To demonstrate that the observed mass peak in urine was indeed hepcidin-25, we incubated
a urine sample with anti-hepcidin O/N at 4°C, before measuring using WCX-TOF MS [18].
Statistical Analysis
Data are presented as mean values ± SD. Statistical analysis of results was performed by Stu-
dent T-test. using Statgraphics 5.1 program (Manugistics, USA). Statistically significant differ-
ences between parameters of piglets from control group vs iron supplemented group on 28th
day of experiment were denoted by one and two asterisks at P0.05 and P0.01, respectively.
Correlation between quantitative variables were assessed using Spearman rank correlation test.
Results and Discussion
Anemia is one of the World Health Organization's top 10 target diseases for treatment and pre-
vention [19] and dietary iron deficiency is one of the most frequently occurring causes of this
disorder. In consequence, iron deficiency anemia (IDA) has been recognized as a widespread
nutritional deficiency in humans with high prevalence in neonatal period [20]. Our previous
studies have indicated that young piglets provide a convenient model for exploring molecular
mechanisms underlying neonatal IDA as well as for testing the effectiveness of various iron
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supplementation strategies [14], [15]. Thus, the expression of hepcidin, one of the most impor-
tant factors in the pathogenesis of disorders of iron metabolism was investigated in both ane-
mic and iron supplemented piglets [14], [15]. We showed that it was induced at the mRNA
level in the liver of piglets supplemented intramuscularly with a large amount of iron dextran,
a procedure widely used in the swine industry [14]. We have also found substantially elevated
levels of hepcidin-25 in the plasma of those piglets using a combination of weak cation
exchange chromatography and time of-flight mass spectrometry (WCX-TOFMS) [15]. In con-
trast, in anemic piglets hepcidin-25 was barely detectable in the plasma [15]. From these stud-
ies we concluded that hepcidin is a promising marker for the diagnosis and management of
IDA in newborn piglets. Similar conclusions about the usefulness of hepcidin assessment in the
serum have been drawn from studies on mice [21] and humans [7].
Hepcidin was originally purified from human urine [22] and before being identified as the
key iron regulatory peptide, it was perceived as an antimicrobial factor.
Due to its small size (2.7 kDa), hepcidin molecule is in part eliminated from blood by glo-
merular filtration, but then it is taken up and degraded in the proximal tubule. A small fraction
of the filtered hepcidin passes intact into the urine where it is readily detectable. To verify the
usefulness of urine hepcidin as a marker of iron status in piglets, we quantified hepcidin-25 in
urine samples collected from 28-day old iron-deficient and iron-replete piglets using the previ-
ously described method for pig plasma hepcidin measurement (Fig 1). Fig 1A shows the over-
time increase of a mass peak of m/z 2749 (which correlates to the m/z of human hepcidin-25),
in the urine profiles of iron dextran-treated pigs, but not in that of control animals. Using
immunocapture with an anti-hepcidin antibody, we were able to remove this particular mass
peak from the urine profile, confirming its identity as pig hepcidin-25 (Fig 1B). The concentra-
tion of urinary pig hepcidin-25, corrected for urine creatinine concentration, reflected plasma
pig hepcidin-25 concentrations as determined by Spearman rank correlation (Fig 1C).
Iron was the first biological factor shown to induce hepcidin expression [2] and there is an
experimental evidence that both high saturation of plasma transferrin with iron (calculated as
the ratio of plasma iron to total iron-binding capacity) [23] and hepatic iron loading [2] stimu-
late hepcidin synthesis. The rationale for choosing 28-day old iron-deficient and iron-supple-
mented piglets for our study was that those animals display quantitatively two opposite iron
metabolism profiles as evidenced by large differences in hemoglobin concentration (5.73±0,77
vs 12.37±0.61 g/dL) (Fig 2A), plasma iron level (8.85±2,49 vs 151.63±27.85) (Fig 2B), transfer-
rin saturation with iron (1.22±0.43 vs 52.18±10.41%) (Fig 2C) and hepatic non-heme iron con-
tent (0.24±0.07 vs 10.30±0.37 mmol/mg) (Fig 2D; left hand panel). Accordingly, microscopic
analysis of liver sections stained for non-heme iron with Perls’ Prussian Blue shows heavy iron
deposits in piglets injected with iron dextran whereas in anemic piglets hepatic non-heme iron
was not detected (Fig 2D; right hand panel). Indeed, hematological and biochemical iron indi-
cators demonstrate dramatic deterioration of iron status leading to a severe anemia when no
supplemental iron is administered to piglets. On the other hand, our results confirm the effi-
cacy of routinely used iron therapy with FeDex leading to the improvement of iron parameters
and thus curing iron deficiency. Such opposite conditions of iron status are useful for the vali-
dation of the urine hepcidin-25 assessment method in pigs. Of importance, an advantage of the
pig model for testing urine hepcidin as an iron status marker is due to the fact that iron defi-
ciency is the only cause of anemia in piglets. In principle, other concurring causes known to
increase hepcidin expression such as inflammation [24] are not involved. Accordingly, intra
vitam and post mortem veterinary examination of piglets used in the study did not reveal any
symptoms of inflammation. Thus, pig anemia may be considered as a homogenous model of
IDA, which has nothing to do with the anemia of chronic disease, and therefore the modula-
tion of urinary hepcidin in this condition is inflammation-independent.
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Fig 1. WCX-TOFMS analysis of urine porcine hepcidin. (A) Urine and plasma pig Hepcidin-25 quantification by mass spectrometry. Hepcidin-25
measurements in piglet plasma were performed by peptide enrichment through weak cation exchange chromatography coupled to time-of-flight mass
spectrometry (WCX-TOFMS) [15]. The spectra (1–4) illustrate the appearance of hepcidin-25 in plasma on day 3, 14, 21 and 28 upon iron dextran injection
to piglets on day 3 after birth. Spectra 5 and 6 show hepcidin-25 in the urine of piglets on day 28. Spectrum 5 corresponds to piglet injected with iron dextran
on day 3 and spectrum 6 corresponds to non-supplemented, control piglet. IS—internal standard. (B) Immune capture of pig hepcidin-25 and isoform
hepcidin-20 in piglet urine. Pig urine was incubated with anti-hepcidin overnight at 4°C, and subsequently hepcidin was measured byWCX-TOFMS.
Hepcidin was almost not detectable in the urine sample incubated with anti-hepcidin antibody (upper spectrum); in the spectrum below (pig urine without anti-
hepcidin antibody) both a high hepcidin-25 peak and a hepcidin-20 peak (mass 2152 Da) are present. (C) Correlation of pig hepcidin-25 in plasma with pig
hepcidin-25 in urine measured with WCX-TOF-MS in piglets injected with iron dextran. Data from 4 measurements of urine and 4 measurements of plasma
samples from day 28 were used for the statistical calculations. Spearman correlation r 0.9063, p = 0.0067.
doi:10.1371/journal.pone.0136695.g001
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Urine hepcidin-25 concentrations measured in anemic and iron-supplemented piglets were
0.045 and 19.25 nmol/mmol creatinine, respectively (Fig 2C). Considering the fact that piglets
supplemented with FeDex accumulated toxic amount of iron in the liver as we demonstrated
previously [14], this difference between piglets from two experimental groups is much greater
than that found in anemic and iron-deficient patients [25]. Importantly, urine hepcidin-25
Fig 2. Hemoglobin levels, transferrin saturation, plasma iron level and hepatic non-heme iron content/distribution in control and iron
supplemented piglets. (A) Hemoglobin level. Values are expressed as the mean ± S.D. for liver samples obtained from 7 piglets from each group. (B)
Plasma iron levels and (C) iron transferrin saturation were measured and calculated as described in Material and Methods. Values are expressed as the
mean ± S.D. for liver samples obtained from 7 piglets from each group. (D) Hepatic non-heme iron content and distribution were measured and examined as
described in Materials and Methods. A high magnifications present deposits of iron or its absence in iron dextran injected and control piglets, respectively.
Values are expressed as the mean ± S.D. for liver samples obtained from 7 piglets from each group. Statistically significant differences are indicated
(*P0.05; **P0.01).
doi:10.1371/journal.pone.0136695.g002
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levels in both groups of piglets were highly correlated with hepatic non-heme iron content
(r = 0.8061; Fig 3B) and to a lesser degree with iron transferrin saturation (r = 0.6242; Fig 3C).
Advantages and limitations of using urine hepcidin as marker of iron status have been
exhaustively reviewed by [7]. An important criterion of its reliability is the correlation between
urine hepcidin concentration and plasma level of biologically active 25-amino acid peptide.
Urine hepcidin quantification in piglets may be helpful for understanding hepcidin fate, start-
ing from the transcriptional induction of Hamp gene in the liver, through hepcidin secretion
Fig 3. Correlations between urine hepcidin and hepatic/plasma hepcidin expression, iron transferrin saturation and hepatic non-heme iron
content.Urine hepcidin-25 levels were measured in control and iron supplemented piglets, and plotted against: (A) hepcidin mRNA levels, Spearman
correlation r = 0.8061, p = 0.0049; (B) hepatic non-heme iron content, Spearman correlation r = 0.8061, p = 0.0049; (C) hepatic non-heme iron content,
Spearman correlation r = 0.6242, p = 0.0537. In each correlation 12 couples of examined parameters on day 28 were used for the statistical calculations.
doi:10.1371/journal.pone.0136695.g003
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into the bloodstream and finally its filtration by renal glomeruli to urine. In our study, we pro-
vide a comprehensive evaluation of hepcidin expression in piglets including its mRNA abun-
dance in the liver (Fig 4A), plasma (Fig 4B) and urine hepcidin-25 concentrations (Fig 4C). We
found that urine hepcidin-25 was highly correlated with hepatic hepcidin mRNA abundance
(r = 0.8061; Fig 3A). Accordingly, a significant positive correlation between urine and serum
hepcidin was reported in healthy controls and patients with perturbations of iron metabolism
Fig 4. Hepatic hepcidin mRNA expression and plasma and urine hepcidin concentrations in control and iron supplemented piglets. (A) Real-time
quantitative PCR analysis of hepcidin mRNA expression in the liver of control and iron-supplemented piglets. The histogram displays hepcidin mRNA levels
in arbitrary units (mean ± S.D., n = 7). (B) Plasma hepcidin levels determined by the method described recently [15]. (C) Urine hepcidin levels determined by
theWCX-TOFMSmethod described under materials and methods section. Values shown in (B) and (C) represent the mean of plasma and urine hepcidin
levels of 6 and 6 samples from control and iron supplemented piglets, respectively. Statistically significant differences are indicated (* P0.05; ** P0.01).
doi:10.1371/journal.pone.0136695.g004
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[25], [26], [27] as well as in transgenic mouse models of iron overload and iron deficiency [28].
However, urine hepcidin concentrations may not always accurately reflect serum hepcidin con-
centrations [29]. We cannot exclude that the hepcidin derived from kidney (produced by tubu-
lar epithelial cells [30], [31] and/or removed from the urine by tubular reabsorption [30], [31]
contributes to the amount of hepcidin-25 measured in urine samples collected from iron-sup-
plemented piglets. Immunohistochemical analysis performed on mouse, rat and human kid-
neys showed that within the nephron the bioactive form of hepcidin is strongly expressed in
the cortical thick ascending limb (cTAL) and connecting tubules. Moreover, in the epithelial
cells of the cTAL, positive immunoreactive signal was localized in the apical part of the cells,
suggesting that hepcidin is released to the urine. Release of hepcidin synthesized in the kidney
into the urine was confirmed by immunoblot and ELISA analyses [30]. Several studies indicate
positive correlation between iron status in the kidney and renal hepcidin expression [32], [31],
[33], [34]. In particular, recent study on genetic mouse models of iron overload (hepcidin and
hemojuvelin knockout mice) has indicated that there is a positive correlation between the
extent of iron accumulation in the renal tubules and the degree ofHamp gene expression [34].
In the light of these data, it is conceivable that striking differences in urine hepcidin levels
observed between anemic and iron-supplemented piglets are also due to the opposite patterns
of renal iron status. However, although the renal iron content was 2-fold higher in iron supple-
mented piglets compared to controls, the abundance of hepcidin mRNA in the kidney did not
vary between animals from both groups (data not shown). Thus, we can assume that the influ-
ence of hepcidin synthesized in the kidney on the concentration of this peptide measured in
urine was negligible.
In conclusion, this study supports the use of WCX-TOF MS for measuring urine hepcidin
levels as means to assess iron status in piglets. On the basis of our results young pigs emerge as
an appropriate animal model, in which measurement of hepcidin in urine accurately reflects
changes in iron status occurring specifically in response to iron therapy, in the absence of over-
lapping effects of inflammation. Considering the fact that the pig is a major biomedical mam-
malian model for human studies, investigating piglet iron deficiency anemia may be helpful in
understanding the molecular pathophysiological mechanisms of this disorder in pre-term
human neonates displaying very low iron content in their liver.
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